Picture of Zeria Pharmaceutical logo

4559 — Zeria Pharmaceutical News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareConservativeMid CapNeutral

Table: Zeria Pharm -Q1 group results

Aug 4 (Reuters)-  
             Zeria Pharmaceutical Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 3 months ended      3 months ended       Year to  
                Jun 30, 2017        Jun 30, 2016     Mar 31, 2018  
                   LATEST             YEAR-AGO          LATEST     
                   RESULTS             RESULTS         FORECAST    
  Sales             15.97               16.49            68.00     
                 (-3.1 pct)          (+12.0 pct)      (+4.9 pct)   
  Operating        597 mln               1.72             5.00     
                 (-65.3 pct)         (+67.4 pct)      (+10.1 pct)  
  Recurring        663 mln               1.83             5.00     
                 (-63.8 pct)        (+208.1 pct)      (+12.7 pct)  
  Net              657 mln               1.33             3.80     
                 (-50.5 pct)         (+49.0 pct)      (+7.2 pct)   
  EPS             12.39 yen           25.01 yen        72.34 yen   
  Ann Div                             32.00 yen        34.00 yen   
  -Q2 div                             16.00 yen        17.00 yen   
  -Q4 div                             16.00 yen        17.00 yen   
   
  NOTE - Zeria Pharmaceutical Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4559.T  
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on Zeria Pharmaceutical

See all news